Drug profile · INN
pilocarpine
ISOPTO CARPINE
pilocarpine (ISOPTO CARPINE) is a muscarinic acetylcholine receptor m3 agonist. Associated with Novartis Pharmaceuticals. Route of administration: ophthalmic. Current US regulatory status: approved.
Drug details — pilocarpine
- US status
- approved
- Class
- —
- Route
- OPHTHALMIC
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
pilocarpine (ISOPTO CARPINE) is a muscarinic acetylcholine receptor m3 agonist. Associated with Novartis Pharmaceuticals. Route of administration: ophthalmic. Current US regulatory status: approved.
Key facts
Mechanism of action
Muscarinic acetylcholine receptor M3 agonist
Primary target: Muscarinic acetylcholine receptor M1
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| TGA | approved | — |
Related & competitor drugs
Frequently asked questions
What is pilocarpine?
pilocarpine (ISOPTO CARPINE) is a muscarinic acetylcholine receptor m3 agonist. Associated with Novartis Pharmaceuticals. Route of administration: ophthalmic. Current US regulatory status: approved.
What is the brand name for pilocarpine?
ISOPTO CARPINE is a marketed brand name for pilocarpine. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of pilocarpine?
pilocarpine has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.